MOUNTAIN VIEW, Calif., Jan. 11, 2011 /PRNewswire/ —
AccessClosure, Inc., the U.S. market leader in extravascular
closure devices, announced today the launch of its next generation
product, the Mynx Cadence Vascular Closure Device (VCD). With
its simpler design and improved ease-of-use, Mynx Cadence offers
physicians smoother device deployment while maintaining all the
benefits of the original Mynx.
(Logo: http://photos.prnewswire.com/prnh/20110111/SF27857LOGO)
“We are extremely excited about the launch of the Mynx Cadence,”
said Gregory D. Casciaro, President and CEO of AccessClosure.
“Designing enhanced solutions for vascular closure is our
top priority and the design changes incorporated into the Mynx
Cadence make it easier to use while maintaining the same feel our
users have grown accustomed to. We believe this device
provides an excellent platform for growth as we continue to expand
our user base.”
Three design changes on the new Mynx Cadence device make it
easier and more consistent to deploy. A definitive shuttle
stop when deploying the sealant reduces the possibility of
over-shuttling. Additionally, a single marker on the advancer
tube removes any guesswork around sealant compression.
Finally, a new sealant sleeve protects the sealant during
deployment and shortens the procedure time by eliminating the need
to pre-soak during device preparation. These changes result
in more consistent sealant delivery every time.
“My initial experience with the Mynx Cadence has been very
positive,” said Elias Kassab, MD, FACC, an Interventional
Cardiologist from Oakwood Hospital in Detroit, Michigan. “The
design changes inspire increased confidence in the device, but I
don’t feel that I’ve lost any of the tactile feedback I’m used to
with the Mynx. These changes truly improve the experience of
deploying the
‘/>”/>
SOURCE
